RegeneRx Biopharmaceuticals, Inc. (NYSEMKT:RGN)
CAPS Rating:
The Company is a biopharmaceutical company that focuses on the discovery and development of novel molecules to accelerate tissue and organ repair.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No one has written a Pitch for RGN yet. Tell us why you think RGN will outperform or underperform the market.
RSS Headlines
Fool UK
